Company Earnings Update 3 minutesRegister for Free AccessWalgreens Boots Alliance (NYSE: WBA) 2Q19 Results: Pricing and Reimbursement Pressures Hit Earnings; Company Lowers FY19 EPS Guidance Coresight Research April 3, 2019 Executive Summary Walgreens Boots Alliance reported 2Q19 revenues of $34.5 billion, in line with the consensus estimate and up 4.6% year over year. Diluted EPS came in at $1.24, down 8.8% year over year and below the consensus estimate of $1.50. Comps for the Retail Pharmacy USA business fell 3.8%, while Retail Pharmacy International comps decreased 1.4%. For FY19, Walgreens expects flat adjusted EPS, revised down from 7–12% growth. Please Login to read the full report. Not a member? Register for a free user account. This document was generated for Other research you may be interested in: Amazon India Prime Day 2023: Preview—A Focus on Convenience and Value, Plus Engagement Through Livestreaming and GamificationRetail Shrink and ORC: Is Self-Checkout on the Way Out? US Retailers Scale Back To Fight TheftSeasonal Shopping, 1Q24—Expectations for Valentine’s Day, Easter and Presidents’ Day: US Consumer Survey Insights ExtraFive Ways AI Is Being Used in Drugstore Retail
